Navigation Links


KIACTA in other areas

Kiacta New Drug Application

Kiacta information from Drugs.com, includes Kiacta side effects, interactions, indications ... submits a complete response to FDA approvable letter for Kiacta ...

Kiacta New Drug Application

Fibrillex information from Drugs.com, includes Fibrillex side effects, interactions, indications ... Moves Eprodisate (Kiacta) Drug Development Program ...

Neurochem - Research Activities

Eprodisate (KIACTA™) is under regulatory review for marketing approval by the ... Eprodisate (KIACTA™) has received orphan drug status in the United States, the ...

Neurochem Must Wait

The Motley Fool - The FDA delays a regulatory decision on Neurochem's lead compound. ... Kiacta is a drug candidate developed to treat a rare condition, Amyloid A ...

Neurochem Withdraws Its Marketing Authorisation Application For Kiacta ...

The European Medicines Agency (EMEA) has been formally notified byNeurochem Luxco II SARL of its decision to withdraw the application fora centralised marketing ...

Cash Problems for Bellus Health

Cash Problems for Bellus Health-The resumption of phase III trials for Kiacta will lead to a significant increase in research and development spending.
Other TagsBritishBritishFightFightFightFightHundredsCitiesCitiesTransplantedOther Contentsneurofibromatosisneurofibromatosisneurologyneurologyneurologyneurologyneurologydeficitdeficitdeficitdeficitdeficitdeficitneurologicneurologicneurologicneurologicneuromaneuromaneurosurgeryneurosurgeryneurosurgeryneurosurgeryneurosisneutropenianeutropenianeutropenia